Form 8-K - Current report:
SEC Accession No. 0001193125-24-075385
Filing Date
2024-03-22
Accepted
2024-03-22 16:49:31
Documents
15
Period of Report
2024-03-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d735520d8k.htm   iXBRL 8-K 25800
2 EX-5.1 d735520dex51.htm EX-5.1 11566
6 GRAPHIC g735520snap1.jpg GRAPHIC 3747
  Complete submission text file 0001193125-24-075385.txt   169140

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vcyt-20240322.xsd EX-101.SCH 2854
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcyt-20240322_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcyt-20240322_pre.xml EX-101.PRE 11264
18 EXTRACTED XBRL INSTANCE DOCUMENT d735520d8k_htm.xml XML 3641
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36156 | Film No.: 24775938
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)